Viyash Scientific (BOM:512529) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:512529 Viyash Scientific Ltd BOM:512529
60 GF Score
Price ₹277.10
GF Value ₹175.57
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Viyash Scientific FFO?

FFO (Funds from operations) only applies to REITs.

BOM:512529
60GF Score
Viyash Scientific Ltd BOM:512529
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Viyash Scientific (BOM:512529) Overvalued in 2026?

Based on GuruFocus' analysis, Viyash Scientific stock appears to be overvalued. The current stock price of ₹277.10 is trading 57.8% above its estimated GF Value™ of ₹175.57. GuruFocus considers Viyash Scientific to be Significantly Overvalued.

Key valuation signals for BOM:512529:

  • FFO:
  • GF Value™: ₹175.57 vs. price of ₹277.10 (57.8% above fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the BOM:512529 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Viyash Scientific Business Description

Other Exchanges VIYASH:India
Address Road No.6, Kakatiya Hills, 3rd Floor, Srivalli’s Corporate, Plot No. 290, Guttala Begumpet, Jubilee Hills, Madhapur, Survey number 33 34P to 39, Hyderabad, KA, IND, 500033
Viyash Scientific Ltd is a pharmaceutical company with activities spanning formulations, active pharmaceutical ingredients (APIs), and intermediates. It is focused on research and development infrastructure for APIs and formulations. Its product portfolio spans several therapeutic areas, including ARV, cardiovascular, central nervous system, analgesics, antibiotics, antihistamines, diabetes, gastrointestinal, anticoagulants, and oncology.
60GF Score

Get the complete analysis for BOM:512529

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹277.10
Price
₹175.57
GF Value